These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21359640)

  • 1. Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei.
    Begley DW; Hartley RC; Davies DR; Edwards TE; Leonard JT; Abendroth J; Burris CA; Bhandari J; Myler PJ; Staker BL; Stewart LJ
    J Struct Funct Genomics; 2011 Jul; 12(2):63-76. PubMed ID: 21359640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the success of fragment screening by X-ray crystallography.
    Davies DR; Begley DW; Hartley RC; Staker BL; Stewart LJ
    Methods Enzymol; 2011; 493():91-114. PubMed ID: 21371588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of 2-amino-4-hydroxypyrimidine-5-carboxylates and binding to Burkholderia pseudomallei 2-C-methyl-d-erythritol-2,4-cyclodiphosphate synthase.
    Watkins SM; Ghose D; Blain JM; Grote DL; Luan CH; Clare M; Meganathan R; Horn JR; Hagen TJ
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126660. PubMed ID: 31521478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide-dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei.
    Nebl S; Alwan WS; Williams ML; Sharma G; Taylor A; Doak BC; Wilde KL; McMahon RM; Halili MA; Martin JL; Capuano B; Fenwick RB; Mohanty B; Scanlon MJ
    J Biomol NMR; 2020 Nov; 74(10-11):595-611. PubMed ID: 32761504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of IspF from Plasmodium falciparum and Burkholderia cenocepacia: comparisons inform antimicrobial drug target assessment.
    O'Rourke PE; Kalinowska-Tłuścik J; Fyfe PK; Dawson A; Hunter WN
    BMC Struct Biol; 2014 Jan; 14():1. PubMed ID: 24410837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of isoprenoids that bind in the intersubunit cavity of Escherichia coli 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase by complementary biophysical methods.
    Kemp LE; Alphey MS; Bond CS; Ferguson MA; Hecht S; Bacher A; Eisenreich W; Rohdich F; Hunter WN
    Acta Crystallogr D Biol Crystallogr; 2005 Jan; 61(Pt 1):45-52. PubMed ID: 15608374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of two drug-like fragments that bind to the same cryptic binding pocket of Burkholderia pseudomallei DsbA.
    Petit GA; Mohanty B; McMahon RM; Nebl S; Hilko DH; Wilde KL; Scanlon MJ; Martin JL; Halili MA
    Acta Crystallogr D Struct Biol; 2022 Jan; 78(Pt 1):75-90. PubMed ID: 34981764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of betaine aldehyde dehydrogenase from Burkholderia pseudomallei.
    Beard DK; Subramanian S; Abendroth J; Dranow DM; Edwards TE; Myler PJ; Asojo OA
    Acta Crystallogr F Struct Biol Commun; 2022 Feb; 78(Pt 2):45-51. PubMed ID: 35102892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double mutation of Escherichia coli2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase disrupts six hydrogen bonds with, yet fails to prevent binding of, an isoprenoid diphosphate.
    Sgraja T; Kemp LE; Ramsden N; Hunter WN
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jul; 61(Pt 7):625-9. PubMed ID: 16511114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural analysis of trehalose-6-phosphate phosphatase from Burkholderia pseudomallei: Insights into the catalytic mechanism.
    Suthisawat S; Gourlay LJ; Bolognesi M; Boonyuen U; Vanaporn M
    Biochem Biophys Res Commun; 2020 Mar; 523(4):979-984. PubMed ID: 31973820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei.
    Zhang Z; Jakkaraju S; Blain J; Gogol K; Zhao L; Hartley RC; Karlsson CA; Staker BL; Edwards TE; Stewart LJ; Myler PJ; Clare M; Begley DW; Horn JR; Hagen TJ
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6860-3. PubMed ID: 24157367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.
    Ramsden NL; Buetow L; Dawson A; Kemp LA; Ulaganathan V; Brenk R; Klebe G; Hunter WN
    J Med Chem; 2009 Apr; 52(8):2531-42. PubMed ID: 19320487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ensemble of structures of Burkholderia pseudomallei 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase.
    Davies DR; Staker BL; Abendroth JA; Edwards TE; Hartley R; Leonard J; Kim H; Rychel AL; Hewitt SN; Myler PJ; Stewart LJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Sep; 67(Pt 9):1044-50. PubMed ID: 21904048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of sedoheptulose-7-phosphate isomerase from Burkholderia pseudomallei reveals a zinc binding site at the heart of the active site.
    Harmer NJ
    J Mol Biol; 2010 Jul; 400(3):379-92. PubMed ID: 20447408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining functional and structural genomics to sample the essential Burkholderia structome.
    Baugh L; Gallagher LA; Patrapuvich R; Clifton MC; Gardberg AS; Edwards TE; Armour B; Begley DW; Dieterich SH; Dranow DM; Abendroth J; Fairman JW; Fox D; Staker BL; Phan I; Gillespie A; Choi R; Nakazawa-Hewitt S; Nguyen MT; Napuli A; Barrett L; Buchko GW; Stacy R; Myler PJ; Stewart LJ; Manoil C; Van Voorhis WC
    PLoS One; 2013; 8(1):e53851. PubMed ID: 23382856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment screening of infectious disease targets in a structural genomics environment.
    Begley DW; Davies DR; Hartley RC; Edwards TE; Staker BL; Van Voorhis WC; Myler PJ; Stewart LJ
    Methods Enzymol; 2011; 493():533-56. PubMed ID: 21371605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of Burkholderia pseudomallei adenylate kinase (Adk): profound asymmetry in the crystal structure of the 'open' state.
    Buchko GW; Robinson H; Abendroth J; Staker BL; Myler PJ
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1012-7. PubMed ID: 20331978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia pseudomallei d-alanine-d-alanine ligase; detailed characterisation and assessment of a potential antibiotic drug target.
    Díaz-Sáez L; Torrie LS; McElroy SP; Gray D; Hunter WN
    FEBS J; 2019 Nov; 286(22):4509-4524. PubMed ID: 31260169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Structure of a Tetrameric Type II β-Carbonic Anhydrase from the Pathogenic Bacterium
    Angeli A; Ferraroni M; Pinteala M; Maier SS; Simionescu BC; Carta F; Del Prete S; Capasso C; Supuran CT
    Molecules; 2020 May; 25(10):. PubMed ID: 32408533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Biochemical Analyses Reveal that Chlorogenic Acid Inhibits the Shikimate Pathway.
    Neetu N; Katiki M; Dev A; Gaur S; Tomar S; Kumar P
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.